Elementis plc
Elementis
Elementis is a global leader in high-value rheological mineral additives, founded with roots tracing back to 1844 and headquartered in London, United Kingdom. With annual revenue of $597.5 million (FY2025), the company operates specialty mineral processing facilities in the US, UK, and Netherlands. Elementis represents the pinnacle of transforming commodity minerals into extreme-value functional ingredients — leveraging unique natural hectorite clay reserves processed through highly proprietary physical delamination and chemical modification to command a 32.4% operating margin in personal care.
Strengths: Near-monopoly position in high-purity natural hectorite clay supply, a mineral resource so rare that few substitutes exist for premium rheological control applications; exceptional operating margin of 21.2% overall and 32.4% in personal care, demonstrating the extreme value-add of deep mineral processing; pure-play specialty chemicals strategy through aggressive divestment of non-core pharmaceutical excipients business enables focused R&D investment; 20% capacity expansion at US St. Louis facility through debottlenecking demonstrates operational efficiency gains without major capex; strategic Alchemy acquisition strengthens natural cosmetic mineral portfolio.
Weaknesses: Small absolute revenue base (<$600 million) limits competitive scale against diversified mineral giants; extreme dependence on a single rare mineral resource (hectorite) creates geographic concentration risk; niche market positioning makes organic growth ceiling relatively low compared to broader industrial mineral competitors.Read MoreShow Less
Strengths: Near-monopoly position in high-purity natural hectorite clay supply, a mineral resource so rare that few substitutes exist for premium rheological control applications; exceptional operating margin of 21.2% overall and 32.4% in personal care, demonstrating the extreme value-add of deep mineral processing; pure-play specialty chemicals strategy through aggressive divestment of non-core pharmaceutical excipients business enables focused R&D investment; 20% capacity expansion at US St. Louis facility through debottlenecking demonstrates operational efficiency gains without major capex; strategic Alchemy acquisition strengthens natural cosmetic mineral portfolio.
Weaknesses: Small absolute revenue base (<$600 million) limits competitive scale against diversified mineral giants; extreme dependence on a single rare mineral resource (hectorite) creates geographic concentration risk; niche market positioning makes organic growth ceiling relatively low compared to broader industrial mineral competitors.
Listed market data
ELM · LSE · weeklyHistory →- Market cap
- $1.4 B
- Share price
- GBP 1.93
- 1Y change
- +15.3%
- Recent change
- +1.2%
- Since first close
- -11.3%
- Revenue (TTM)
- $590 M
11-03 → 11-04
from 1988-07
Financial history
Full market history- 2026-11GBP 1.93$1.4 B+4.3%
- 2026-10GBP 1.85$104 B0.0%
- 2026-09GBP 1.85$104 B+3.5%
- 2026-08GBP 1.79$101 B+2.8%
- 2026-07GBP 1.74$98 B-1.7%
- 2026-06GBP 1.77$99.7 B+15.2%
- 2026-05GBP 1.54$86.6 B+0.1%
- 2026-04GBP 1.54$86.4 B+3.8%
- 2026-03GBP 1.48$83.3 B-10.8%
- 2026-02GBP 1.66$1.2 B+2.7%
- 2026-01GBP 1.62$1.2 B-2.7%
- 2025-12GBP 1.66$1.2 B—
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Manufacturer
- Insiders
- 4.23%
- Institutions
- 76.55%(103 holders)
- Free float
- 79.93%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →5 latest headlines1- Elementis (LSE:ELM) Draws Fresh Value Interest After Cash Flow Focus Turns Heads - Simply Wall Streetsimplywall.st2026-10-18
- Elementis (LSE:ELM) Additives Lift Pricing Among UK Mid-Caps - Kalkine Mediakalkinemedia.com2026-10-16
- Elementis (LSE:ELM) Stock Looks Below Fair Value On Cash Flowfinance.yahoo.com2026-10-16
- Elementis (LSE:ELM) Stock Looks Below Fair Value On Cash Flow - Yahoo Financefinance.yahoo.com2026-10-16
- Elementis Personal Care Expands Distribution Network for Alchemy Ingredients Portfolio - Happi | Household And Personal Products Industrywww.happi.com2026-10-02
• Personal care ingredients including BENTONE® for cosmetics and skincare
• Coatings additives for paints, inks, and industrial finishes
• Industrial specialty chemicals for oilfield and construction applications
• Natural cosmetic minerals for luxury beauty brands
• Hectorite clay mining and processing with near-monopoly market position
Quick Facts
Headquarters
London, United Kingdom
Founded
1844
Employees
~1,500
Revenue
$598 M (FY2025)
Market cap
$1.4 B
Factories
Specialty mineral processing facilities in the US (St. Louis), UK, and the Netherlands with proprietary hectorite clay refining and rheological additive production lines
Presence
Global distribution serving personal care, coatings, and industrial specialty chemical markets in 50+ countries
Listing
London Stock Exchange: ELM
Categories
10 categories · scroll for more
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Johnson & Johnson (J&J)· $658 B
- AbbVie Inc.· $521 B
- Merck & Co., Inc.· $369 B
- The Home Depot, Inc.· $328 B
- Novartis AG· $282 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website Listed (LSE: ELM) , • Elementis Official Website
• LSE Company Page
• Reuters Financial Profile
• Bloomberg Data
